HIT Consultant

JUNE 12, 2023

What You Should Know: Range Biotechnologies (Range Bio) announced $5.2M Thus, developing more effective ways to diagnose, treat, and prevent diseases such as cardiovascular disease, cancer, COPD, MS, and more. Proteomics, the study of proteins in the body, has the potential to improve human health in several ways.

Biotechnology 52

Biotechnology Prevention Life Sciences 52

HIT Consultant

OCTOBER 13, 2022

What You Should Know: – ChristianaCare recently announced it has spun out its first commercial biotechnology private startup company, named CorriXR Therapeutics. The CorriXR Therapeutics team includes experienced biotechnology executives and world-renowned scientists and clinicians. The executive team is led by Eric Kmiec, Ph.D.,

Biotechnology 98

Biotechnology Regulations Prevention Integration 98

HIT Consultant

OCTOBER 14, 2022

Co-Founder, President, & CEO of Obatala Sciences, Inc. These solutions, provided to pharmaceutical companies, government labs, and researchers, are designed to accelerate the study and prevention of diseases in the fields of obesity, diabetes, cancer, and regenerative medicines. Trivia Frazier, Ph.D.,

Biotechnology 98

Biotechnology Pharmaceuticals Healthcare Innovation Prevention 98

HIT Consultant

OCTOBER 9, 2024

What You Should Know: – clock.bio , a healthspan biotechnology company based at the Milner Therapeutics Institute in Cambridge, has secured $5.3M A Vision for Increased Healthspan clock.bio’s mission is to increase human healthspan by developing treatments that prevent and treat age-related diseases.

Biotechnology 97

Biotechnology Prevention Life Sciences 97

Cloud Blogs

MAY 18, 2021

Adaptive Biotechnologies is a commercial-stage biotechnology company focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease.

Biotechnology 88

Biotechnology Life Sciences Healthcare Innovation Healthcare 88

HIT Consultant

SEPTEMBER 12, 2022

Freenome is a biotechnology company with a comprehensive multiomics platform for the early detection of cancer using a standard blood draw. will help LHN members bring innovative cancer prevention testing to the communities they serve. A Comprehensive Multiomics Platform for the Early Detection of Cancer. Trial participation?will

Biotechnology 98

Biotechnology Prevention Health Data Hospitals 98

HIT Consultant

MAY 30, 2023

Sonia Fischer, Customer Integrations Manager, IQVIA In the age of biotechnology , biosample collection has become an essential part of medical research. The extra effort may require a greater initial investment, but it could potentially prevent the need to recruit additional patients.

Biotechnology 98

Biotechnology Integration Prevention Patient Experience 98